Global Navigation
Recent news
-
PRA expands its European operations with new UK and Dutch offices
Will open new base in Utrecht and relocate its existing Reading, UK offices to a larger site
22 May 2012 -
Daiichi to research cancer drugs with Japan’s National Cancer Centre
Deal also covers promotion of public health
22 May 2012 -
UK bets on information power in new online health strategy
Ten-year plan aims to transform the way NHS information is used
22 May 2012 -
Boehringer Ingelheim's Dr Susan Anton joins Icon
The CRO also appoints Dr Pui Leung, boosting its early phase and epidemiology and risk management teams
22 May 2012 -
Xarelto backed for ACS ahead of FDA advisory panel
Documents released showing agency supports Johnson & Johnson/Bayer's drug in extra indication
22 May 2012 -
Bayer’s Nexavar fails in another lung cancer study
Dents prospects for approval in extra indication
22 May 2012 -
GSK agrees to co-promote Auxilium’s Testim in US
US biopharma Auxilium raises financial guidance for year based on deal for its testosterone gel brand
22 May 2012 -
UCB signs epilepsy research pact with Imperial College London
Belgian pharma firm also launches epilepsy centre in Glasgow during National Epilepsy Awareness Week
21 May 2012 -
Future of health is in cloud computing and big data, says former Apple CEO
John Sculley forecasts huge increases in computing power and cheaper online storage will help solve problems with healthcare
21 May 2012 -
Indian drug regulator 'colluded with pharma companies'
Cipla, Sun Pharma, Novartis and Bayer all implicated following Ministry of Health report into regulatory standards
21 May 2012 -
Biomarker analysis revives fortunes of Amgen's rilotumumab
Will launch phase III trial in patients with gastric cancer a year after halting development
21 May 2012 -
Phillip Frost to remain chair of Teva Pharmaceutical
Re-elected by board for at least three more years
21 May 2012 -
Watson faces lawsuit over generic contraceptive
Warner Chilcott issues challenge over copycat version of Lo Loestrin Fe
21 May 2012 -
EMA lags behind FDA for drug reviews
Drugs reviewed more rapidly and reach market more quickly in US than in Europe says NEJM study
18 May 2012 -
Stem cell drug first for Osiris
US firm's Prochymal approved in Canada to treat bone marrow transplant complication
18 May 2012 -
J&J's Nucynta tackles pain in people with diabetes
Phase III success in diabetic peripheral neuropathy
18 May 2012 -
Generic Plavix debuts in US
Sanofi and Bristol-Myers Squibb sales to be hit by copycat versions from Mylan, Teva and more
18 May 2012 -
HGS attempts to thwart GSK takeover plans
Genome specialists also in talks with alternative buyers
18 May 2012 -
Philippe Calais appointed CEO of Antisense Pharma
Joins as German biopharma aims to take cancer drug trabedersen to phase I
18 May 2012 -
Piramal pays $635m for US data firm
Decision Resources Group purchase reflects increasing demand for drug market information
17 May 2012 -
Torisel fails to top Bayer’s Nexavar as second-line kidney cancer treatment
Comparative study dents prospects for Pfizer’s drug
17 May 2012 -
Novartis' COPD drug clears phase III trial
Seebri demonstrates improvements in symptoms and lung function
17 May 2012 -
World's first mental health electronic patient record goes online
South London and Maudsley NHS Foundation Trust teams up with Microsoft to unveil MyHealthBox
17 May 2012 -
Merck KGaA targets savings of €300m by 2014
Details on cost-cutting efforts come as first quarter pharmaceutical sales see slight increase
17 May 2012 -
Syndax Pharmaceuticals appoints Luke Evnin to board
Joins as oncology specialists aim to bring lead candidate entinostat to phase III
17 May 2012 -
MRC partners with academia to launch imaging centre for drug research
Imanova will provide platform for pharma companies to study drugs in the human body to speed up development process
16 May 2012 -
Half of med devices firms use social media
Survey finds social media is an integral part of the medical devices industry
16 May 2012 -
UK must curb exports if drug shortages are to be resolved
All-Party Pharmaceutical Group report says shortages are diverting attention from patient care
16 May 2012 -
Landmark study will test Genentech drug for Alzheimer's prevention
Roche unit will collaborate with the Banner Alzheimer's Institute and the National Institutes of Health to study crenezumab
16 May 2012 -
GSK acquires Cellzome to boost early-stage drug discovery
Says deal with chemical proteomics company will help it bring new drugs to market faster
16 May 2012 -
Antares Pharma appoints LeRoux Jooste SVP pharma sales and marketing
Joins US self-injection and topical gel specialists from Cephalon
16 May 2012 -
Janssen's Zytiga access scheme and patient data win over NICE
Pharma company's prostate cancer drug recommended in draft guidance after NICE reconsiders its earlier verdict
16 May 2012 -
Medivir appoints Actelion's Henric Juserius to senior commercial role
As executive vice president, commercial he will head up all the company's activities in the area
15 May 2012 -
GSK defends UK tax record after BBC investigation
Television documentary claims the UK-based pharma company arranged secret deals in Luxembourg
15 May 2012 -
FDA updates Gilenya label after safety review
Novartis' multiple sclerosis drug is contra-indicated in patients with a history of heart disease or stroke
15 May 2012 -
Lundbeck buoyed by data on new antidepressant
LU AA21004 could help company cope with loss of patent protection for Cipralex/Lexapro
15 May 2012 -
Pharma consortium extends UK academic collaboration
AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Merck Serono and Pfizer extend their partnership with University of Dundee-MRC to 2016
15 May 2012 -
European Parliament 'not amused' with EMA failures
Won't sign-off medicines agency’s budget and wants procurement action plan and impartiality assurances
15 May 2012 -
Jeffrey Kraws to chair Synthetic Biologics
US biotech also appoints Dr Carol Reed as senior VP of clinical and regulatory affairs
15 May 2012 -
Gilead’s Truvada receives US backing in HIV prevention
Positive step for milestone drug that offers alternative approach to tackling virus
14 May 2012 -
Takeda unveils growth plan as profits come under pressure
Emerging markets targeted as sales hit by generic competition for Actos
14 May 2012 -
Study finds MSD’s NuvaRing riskier than oral contraceptives
MSD claims findings that vaginal ring carries higher risk of blood clots are compromised
14 May 2012 -
Sanofi launches iPhone blood glucose meter in the US
Signs Apple Store deal for iPhone, iPod touch and iPad compatible device
14 May 2012 -
PMEA 2012 is open for entry
Awards recognise pharma companies that have delivered excellence in their business practices and enhanced the industry's reputation
14 May 2012 -
FDA recommends Arena-Eisai’s weight loss drug Lorqess
Could beat Vivus’ Qnexa to market as first weight loss medicine approved in US since 1999
14 May 2012 -
Former AstraZeneca man Graham Walker joins Idea Pharma
Will work with product teams to bridge gap between clinical and commercial
14 May 2012 -
US doctors' use of iPads and smartphones 'evolving rapidly'
Manhattan Research says 85 per cent of physicians own or use a smartphone for professional purposes
11 May 2012 -
Watson appoints management consultant to oversee Actavis acquisition
Marc Lehnen will lead the company's new global integration management office
11 May 2012 -
IFPMA sets out blueprint for tropical disease R&D
Report outlines "systemic gaps" in current research model
11 May 2012 -
IQWiG backs BMS' Yervoy for melanoma
Bucks trend of negative recommendations from German institute
11 May 2012 -
Botox wins NICE-backing as a migraine treatment
Allergan provides more data to appease NICE concerns about the drug's benefits
11 May 2012 -
NICE gives final rejection to Sanofi’s Jevtana for prostate cancer
Watchdog cites high price and number of side effects
11 May 2012 -
UCB’s Neil Weir to chair ABPI innovation board
Will lead efforts to develop vision for innovation in UK and build international reputation
11 May 2012 -
Teva’s first quarter profit up despite flat European sales
Cephalon purchase boosts US performance
10 May 2012 -
Europe needs new legal basis for health data, says eHealth Task Force
European healthcare also needs fundamental reorganisation if it is to benefit from IT advances
10 May 2012 -
FDA panel backs Pfizer's tofacitinib for arthritis
Drug’s oral administration is advantage over injectable rivals
10 May 2012 -
Uptake of new medicines is a major problem, admits NICE
Chief executive Sir Andrew Dillon says issue needs to be tackled collectively by pharma, the NHS, government and NICE
10 May 2012 -
Erbitux trial shows cancer drug has no benefit after surgery
Merck KGaA’s colon cancer drug no better than standard chemotherapy in study
10 May 2012 -
Lundbeck's commercial operations head Marie-Laure Pochon resigns
Cites 'family and private reasons'
10 May 2012 -
Roche’s Tarceva receives NICE backing for lung cancer
Will compete with AstraZeneca’s Iressa despite lack of comparison data
10 May 2012 -
Teva appoints genetics specialist as its first president of global R&D
Michael Hayden will also serve as chief scientific officer at the generics company
10 May 2012 -
GSK launches hostile $2.59bn bid for Human Genome Sciences
Will target shareholders following board’s decision to reject private approach
09 May 2012 -
UK pharma won’t have to 'trawl internet' for adverse event reports
MHRA confirms that limits of pharmacovigilance responsibility also apply to blogs, chat rooms and social media sites
09 May 2012 -
Pfizer's Robert Clark to move to Novo Nordisk
Will join firm’s US operations as vice president of regulatory affairs
09 May 2012 -
FDA panel turns down Arcalyst use in gout
More safety data needed after Regeneron’s drug linked to increased risk of cancer
09 May 2012 -
Novartis says Sandostatin successor clears phase III
Pasireotide more effective than current therapy in endocrine disorder acromegaly
09 May 2012 -
Celgene hires Thomas Moriarty to lead legal strategy
Joins as general counsel and corporate secretary from Medco Health Solutions
09 May 2012 -
Teva’s generic Lipitor set to save NHS millions
Cheap copy of Pfizer’s cholesterol launches in UK
09 May 2012 -
Novartis 'in negotiations' over price of Lucentis in UK
New study suggests off-label treatment with Roche's Avastin could be as effective as using Novartis' eye drug
09 May 2012
